Cargando…

Prices of combination medicines and single‐molecule antihypertensive medicines in India's private health care sector

More than half of patients with hypertension require two or more medicines to control blood pressure. Combinations of anti‐hypertensive medicines are available as Single Pill Combinations (SPCs) or Single Agent Pills (SAPs). SPCs of two or more anti‐hypertensive medicines facilitate simpler dosing s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Negi, Sagri, Neupane, Dinesh, Sahoo, Swagata Kumar, Mahajan, Tanushree, Swaroop, Kishan, Moran, Andrew E., Sharma, Bhawna, Pathni, Anupam Khungar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678655/ https://www.ncbi.nlm.nih.gov/pubmed/33369089 http://dx.doi.org/10.1111/jch.14143

Ejemplares similares

Research Letter: Antihypertensive Drugs Market in India: An Insight on Size, Trends, and Prescribing Preferences in the Private Health Sector, 2016–2018
por: Sahoo, Swagata Kumar, et al.
Publicado: (2021)

Financial implications of protocol-based hypertension treatment: an insight into medication costs in public and private health sectors in India
por: Sahoo, Swagata Kumar, et al.
Publicado: (2022)

Research Letter: Unmet Need for Hypertension Treatment in India: Evidence from Hypertension Drugs Market Data
por: Pathni, Anupam Khungar, et al.
Publicado: (2021)

Is there transparency in the pricing of medicines in the South African private sector?
por: Bangalee, V, et al.
Publicado: (2018)

Validation of a Practical Approach to Blood Pressure Measurement: Secondary Analysis of Data from a Nationally Representative Survey in India
por: Shivashankar, Roopa, et al.
Publicado: (2021)

Delivering hypertension care in private-sector clinics of urban slum areas of India: the Mumbai Hypertension Project
por: Hegde, Asha, et al.
Publicado: (2022)

Affordability of essential medicine prices in Malaysia’s private health sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2018)

Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2019)

Phone calls for improving blood pressure control among hypertensive patients attending private medical practitioners in India: Findings from Mumbai hypertension project
por: Kannure, Mandar, et al.
Publicado: (2021)

Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa
por: Mattila, Phyllis Ocran, et al.
Publicado: (2021)

A simple six-step guide to National-Scale Hypertension Control Program implementation
por: Cazabon, Danielle, et al.
Publicado: (2021)

Blood from a stone: funding hypertension prevention, treatment, and care in low- and middle-income countries
por: Cohn, Jennifer, et al.
Publicado: (2021)

Outcomes of a hypertension care program based on task-sharing with private pharmacies: a retrospective study from two blocks in rural India
por: Das, Hemanshu, et al.
Publicado: (2023)

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries
por: O'Connell, Kathryn A, et al.
Publicado: (2011)

Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia
por: Kaiser, Andrea Hannah, et al.
Publicado: (2019)

WHO key access antibiotics price, availability and affordability in private sector pharmacies in Pakistan
por: Saleem, Zikria, et al.
Publicado: (2021)

The accountability of the private sector towards citizens in times of crisis: vaccines, medicines and equipment
por: Petelos, Elena, et al.
Publicado: (2021)

Strengthening the Somaliland health system by integrating public and private sector family medicine
por: Mahfud, Muna M., et al.
Publicado: (2021)

Consumers' Knowledge, Attitudes, and Practices Toward Medicine Price Transparency at Private Healthcare Setting in Malaysia
por: Ahmad, Nur Sufiza, et al.
Publicado: (2021)

Price subsidies increase the use of private sector ACTs: evidence from a systematic review
por: Morris, Alexandra, et al.
Publicado: (2015)

PRICE'S TEXTBOOK OF MEDICINE
Publicado: (1956)

Cost-Effectiveness of Improved Hypertension Management in India through Increased Treatment Coverage and Adherence: A Mathematical Modeling Study
por: Das, Hemanshu, et al.
Publicado: (2021)

A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013
por: Kioko, Urbanus, et al.
Publicado: (2016)

Medicine Prices, Availability, and Affordability in Private Health Facilities in Low-Income Settlements in Nairobi County, Kenya
por: Ongarora, Dennis, et al.
Publicado: (2019)

Prices of medicines for the management of pain, diabetes and cardiovascular diseases in private pharmacies and the national health insurance in Tanzania
por: Kirua, Rashid Bakari, et al.
Publicado: (2020)

Medicines Prices and Malaysia—Untangling the Medicines Web
por: Hill, Suzanne
Publicado: (2007)

Overcoming the affordability barrier for effective and high quality life saving malaria medicines in the private sector in rural Uganda: the Consortium for ACT Private Sector Subsidy (CAPSS) pilot study
por: Talisuna, Ambrose O, et al.
Publicado: (2012)

Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data
por: Arinaminpathy, Nimalan, et al.
Publicado: (2019)

PRICE'S TEXTBOOK ON THE PRACTICE OF MEDICINE
Publicado: (1973)

PRICE'S TEXTBOOK OF THE PRACTICE OF MEDICINE
Publicado: (1979)

PRICE'S TEXTBOOK OF THE PRACTICE OF MEDICINE
Publicado: (1966)

Price, availability and affordability of medicines
por: Mhlanga, Brenda S., et al.
Publicado: (2014)

Impact of discounts on medicine prices
por: Schneider, Peter, et al.
Publicado: (2015)

Multi stakeholders of health and industries perspectives on medicine price transparency initiative in private health care settings in Malaysia
por: Sufiza Ahmad, Nur, et al.
Publicado: (2020)

A study of technetium-99m wastage in selected private sector nuclear medicine imaging departments
por: Mathurine, Germaine, et al.
Publicado: (2013)

Childhood cancers in a section of the South African private health sector: Analysis of medicines claims data
por: Otoo, Marianne N., et al.
Publicado: (2020)

Trends in the utilization of medicines sold in the private sector post- registration in South Africa and the implications for similar countries
por: Mpanza, Ntobeko Magnate, et al.
Publicado: (2023)

Antimalarial procurement in private-sector pharmaceutical outlets: decision-making complexities and implications for medicine quality in Tanzania
por: Mshana, Gerry, et al.
Publicado: (2023)

Enhancing medicine price transparency through price information mechanisms
por: Hinsch, Michael, et al.
Publicado: (2014)

How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014
por: Hamzah, NM, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7r731le680e45su10lns8rj49s